Note: Any up-dates are to be completed in different color ink.
k. The student is expected to document all meds the client is currently receiving.
MEDICATION NAME
GENERIC/TRADE INDICATION/ ACTION
CLASSIFICATION
(PHARM) AND
PREGNANCY
CATEGORY
Sedation for obstetrics,
Promethazine hcl surgery, Adjunct with
(Phenergan) epinephrine in
anaphylactic rxs, with
Preg. Cat. C narcotics for postop pain
Symptomatic treatment of
Mosby’s Drug Nsg allergic disorders medicated
Card 337 y histamine. Treatment of
N/V, motion sickness.
Pharmacology for H1 antihistaminic activity
Nsg Care Page 92 due to competitive
inhibition of histamine at H1
histamine receptors on
peripheral cells, drug
exhibits good
anticholinergic, antiemetic,
antipruritic, sedative
properties.
DOSE, ROUTE, TIMES
DOSGE FOOD/DRUG
RANGE INTERACTIONS
(include therapeutic
dose calculation)
MI Obstetric Adult Incompatible with strong
Early labor, 50mg alkaline drugs.
Labor, 25-75mg Compatibilities: amikacin,
PO/MI/Rectal ascorbic acid, chloroquine,
Sedative Adult 25-50 hydromorphone,
mg at bedtime netilmicin, vitamin B/C,
Pediatric 12.5mg at Syringe-atropine,
bedtime butorphanol,
PO/MI/Rectal Preop chlorpromazine,
Adult 25-50mg, cimetidine,
Pediatric 0.5mg/lb dephenhydramine,
PO allergy drperido, fentanly,
Adult 12.5-25mg tid mepridine
or 25mg at bedtime. Unreliable results with
PO/MI/Rectal human chorionic
N/V Adult 25mg q 4- gonadotropin/antihuman
6hr prn chorionic gonadotropin
Pediatric rectal pregnancy test, possible
0.5mg/lb increase in blood glucose.
. Use with anti-cholinergics,
CNS depressants, TCAs
produces additive effects
MAO-I can increase
anticholinergic effects of
antihistamines.
EFFECTS PREGANCY
SIDE EFFECTS FETUS AND/OR NURSING CONSIDERATIONS
NEONATE
Drowsiness, Neonate may Assess hx or hypersensitivity, hx of
dizziness, fatigue, experience heightened peptic ulcer, open-angle glaucoma,
euphoria, blurred drug sensitivity, due bladder obstruction, prostatic
vision, largely to immature hypertrophy, use caution.
hyotension, state of five Administer IM preferred parenteral
palpitations, pharmacokinetic route, Inject deeply into large
tachycardia, process; Drug muscle mass, IV avoid
extrasystole, absorption, protein concentration . 25mg/ml and inject
agranulocytosis, binding of drugs, slowly (,25mg/m) avoid
thrombocytopenia exclusion of drugs perivascular extravasations, intra-
, cholestatic, form he central nervous arterial injection, protect from light
jaundice, drug system(CNS) by the with foil covering, do not use
rash, blood-brain barrier , discolored/precipitated solutions,
photosensitivity, hepatic drug avoid subcutaneous administration.
anicholinergic metabolism, renal drug Have support equipment available
effects, excretion. for anaphylaxis. Avoid exposure to
thickening of moisture/light in storage.
bronchial
secretions.
PHARM